Continuing Resolution Allows FDA To Collect Drug Compounding Fees

FDA will be able to collect new drug compounding user fees authorized by the Drug Quality and Security Act (DQSA) under the continuing resolution that cleared Congress and was signed by President Barack Obama last week. The agency will otherwise have to wait to begin on other new endeavors and projects, said an FDA funding advocate. The continuing resolution, which expires Dec. 11, continues funding the government at fiscal 2014 funding levels. The funding measure grants a request from the...